N
ERAS icon

Nuveen’s Erasca ERAS Stock Holding History

Nuveen’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.79M Buy
543,021
+118,308
+28% +$1.4M ﹤0.01% 1627
2025
Q4 		$1.58M Sell
424,713
-25,343
-6% -$71.3K ﹤0.01% 2393
2025
Q3 		$981K Hold
450,056
– – ﹤0.01% 2632
2025
Q2 		$572K Sell
450,056
-33,527
-7% -$44.9K ﹤0.01% 2838
2025
Q1 		$663K Sell
483,583
-72,121
-13% -$124K ﹤0.01% 2806
2024
Q4 		$1.39M Buy
555,704
+72,121
+15% +$198K ﹤0.01% 2542
2024
Q3 		$1.32M Sell
483,583
-689,023
-59% -$1.94M ﹤0.01% 2635
2024
Q2 		$2.77M Buy
1,172,606
+482,405
+70% +$1.04M ﹤0.01% 2221
2024
Q1 		$1.42M Sell
690,201
-509,751
-42% -$1.02M ﹤0.01% 2555
2023
Q4 		$2.56M Buy
1,199,952
+2,012
+0.2% +$4.24K ﹤0.01% 2298
2023
Q3 		$2.36M Buy
1,197,940
+18,228
+2% +$46.7K ﹤0.01% 2225
2023
Q2 		$3.26M Buy
1,179,712
+468,305
+66% +$1.33M ﹤0.01% 2124
2023
Q1 		$2.14M Buy
711,407
+351,307
+98% +$1.28M ﹤0.01% 2304
2022
Q4 		$1.55M Buy
360,100
+87,419
+32% +$593K ﹤0.01% 2490
2022
Q3 		$2.13M Sell
272,681
-7,189
-3% -$57.9K ﹤0.01% 2370
2022
Q2 		$1.56M Buy
279,870
+36,842
+15% +$241K ﹤0.01% 2568
2022
Q1 		$2.4M Buy
243,028
+213,389
+720% +$2.47M ﹤0.01% 2419
2021
Q4 		$384K Sell
29,639
-13,138
-31% -$225K ﹤0.01% 3129
2021
Q3 		$908K Buy
+42,777
New +$882K ﹤0.01% 3019

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Nuveen's ERAS Position: Q1 2026 in Review

Nuveen increased its Erasca (ERAS) stake by 28% in Q1 2026, buying an estimated $1.4M and bringing the position to 543,021 shares worth $8.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1627.

Nuveen first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Nuveen held 543,021 shares of Erasca worth $8.79M as of Q1 2026.
  • Nuveen bought 118,308 Erasca shares in Q1 2026, an estimated $1.4M.
  • Erasca made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1627 holding.
  • Nuveen first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.